2001;7(6):3959 discussion 399400
While compounded semaglutide itself is not FDA-approved as a final product, the active ingredient is FDA-approved, and compounding pharmacies use FDA-regulated equipment and sterile techniques
DOI: 10.1038/288715a0 PMID: 7453802 Maquart FX, Pickart L, Laurent M, et al
IV is preferred due to variable oral bioavailability (discussed further below)
Clinical evidence The 2013 exenatide proof-of-concept clinical trial involving 45 moderate PD patients displayed possible efficacy concerning part 3 of the Movement Disorders Society Unified Parkinsons Disease Rating Scale (MDS-UPDRS) [17]
~ AlphaMD If youve been hoping peptides might eventually become part of a more legitimate, medically guided treatment conversation, this is the kind of headline that gets your attention fast